The Use of Gemtuzumab Ozogamicin as Salvage Therapy in Patients with Acute Myeloid Leukemia: A Monocentric Real-World Experience

Background and Objectives: Relapsed or refractory acute myeloid leukemia (r/r AML) is a disease with a poor prognosis. Limited treatment options are available in r/r AML. Here, we administered gemtuzumab ozogamicin (GO) as salvage therapy in twenty-four patients with r/r AML. The aim of the study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Açar, İbrahim Halil, Guvenc, Birol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056876/
https://www.ncbi.nlm.nih.gov/pubmed/36984499
http://dx.doi.org/10.3390/medicina59030498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056876/
https://www.ncbi.nlm.nih.gov/pubmed/36984499
http://dx.doi.org/10.3390/medicina59030498

Ejemplares similares